Capricor Therapeutics
CAPR
#7318
Rank
$0.57 B
Marketcap
$9.85
Share price
9.44%
Change (1 day)
77.16%
Change (1 year)

EPS for Capricor Therapeutics (CAPR)

EPS in 2023 (TTM): -$1.17

According to Capricor Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.45. In 2022 the company made an earnings per share (EPS) of -$1.18 a decrease over its 2021 EPS that were of -$0.87.

EPS history for Capricor Therapeutics from 2001 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.17-0.85%
2022-$1.1835.63%
2021-$0.87-7.45%
2020-$0.94-55.45%
2019-$2.11-59.81%
2018-$5.25-1850%
2017$0.30-102.94%
2016-$10.2025.93%
2015-$8.1055.77%
2014-$5.20-39.53%
2013-$8.60-64.78%
2012-$24.41-62.44%
2011-$65.00-31.58%
2010-$95.00-38.71%
2009-$155.00-43.64%
2008-$275.00-5.17%
2007-$290.00427.27%
2006-$55.00340.33%
2005-$12.49
2004N/A
2003N/A
2002N/A
2001N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68-372.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$7.05-387.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-$7.22 194.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$4.35 77.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-$7.55 208.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-$29.29 1,095.51%๐Ÿ‡บ๐Ÿ‡ธ USA